{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:39:09Z","timestamp":1792697949578,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.semnephrol.2020.12.004","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T17:14:00Z","timestamp":1614964440000},"page":"574-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage"],"prefix":"10.1016","volume":"40","author":[{"given":"Abutaleb Ahsan","family":"Ejaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando E.","family":"Garcia Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Roncal-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Sasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk-Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Andres","family":"Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Rodriguez-Iturbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean R","family":"Tolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura G.","family":"Sanchez-Lozada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Lanaspa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2020.12.004_bib0001","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/095952874803100109","article-title":"Observations on the blood and urine of gout, rheumatism and Bright's disease","volume":"31","author":"Garrod","year":"1848","journal-title":"Med Chir Trans"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0002","series-title":"On the diseases of the kidney","author":"Johnson","year":"1852"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0003","series-title":"Uric acid as a factor in the causation of disease. A contribution to the pathology of high arterial tension, headache, epilepsy, mental depression, gout, rheumatism, diabetes, Bright's disease, and other disorders","author":"Haig","year":"1892"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.1897.02440320005001a","article-title":"The cardiovascular and renal relations and manifestations of gout","volume":"29","author":"Davis","year":"1897","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archinte.1924.00120040089007","article-title":"The interpretation of increased blood uric acid in hypertension","volume":"34","author":"Fishberg","year":"1924","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semnephrol.2004.09.002","article-title":"Uric acid, evolution and primitive cultures","volume":"25","author":"Johnson","year":"2005","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0007","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007-2016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0008","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7326\/0003-4819-34-6-1421","article-title":"Serum uric acid in relation to age and physique in health and in coronary heart disease","volume":"34","author":"Gertler","year":"1951","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0009","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0140-6736(66)90005-5","article-title":"Hypertension and hyperuricaemia","volume":"1","author":"Breckenridge","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0895-4356(88)90127-8","article-title":"Gout and coronary heart disease: the Framingham Study","volume":"41","author":"Abbott","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0011","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00005792-196012000-00001","article-title":"The kidney in gout","volume":"39","author":"Talbott","year":"1960","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0049-0172(77)90016-6","article-title":"The gouty kidney","volume":"7","author":"Bluestone","year":"1977","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0014","first-page":"95","article-title":"Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease","volume":"72","author":"Yu","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ki.1986.179","article-title":"Requiem for gouty nephropathy","volume":"30","author":"Beck","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.7326\/0003-4819-131-1-199907060-00012","article-title":"Risk factors for cardiovascular disease: one down, many more to evaluate","volume":"131","author":"Vaccarino","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0017","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men","volume":"350","author":"Choi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0018","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.23245","article-title":"Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey","volume":"59","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0019","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1038\/ncomms3434","article-title":"Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome","volume":"4","author":"Lanaspa","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0020","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1073\/pnas.1713837115","article-title":"High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism","volume":"115","author":"Lanaspa","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0021","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ki.2013.492","article-title":"Fructokinase activity mediates dehydration-induced renal injury","volume":"86","author":"Roncal Jimenez","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0022","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1073\/pnas.1320393111","article-title":"Evolutionary history and metabolic insights of ancient mammalian uricases","volume":"111","author":"Kratzer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0023","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/oxfordjournals.molbev.a004123","article-title":"Loss of urate oxidase activity in hominoids and its evolutionary implications","volume":"19","author":"Oda","year":"2002","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0024","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/175683a0","article-title":"The origin of man","volume":"175","author":"Orowan","year":"1955","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0026","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/evan.20266","article-title":"Fructose, uricase, and the back-to-Africa hypothesis","volume":"19","author":"Johnson","year":"2010","journal-title":"Evol Anthropol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0027","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/15257770902736400","article-title":"Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress","volume":"28","author":"Gersch","year":"2009","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0028","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/15257770802257952","article-title":"Inactivation of nitric oxide by uric acid","volume":"27","author":"Gersch","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0029","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2008.11.029","article-title":"Simultaneous determination of uric acid metabolites allantoin, 6-aminouracil, and triuret in human urine using liquid chromatography-mass spectrometry","volume":"877","author":"Kim","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cca.2005.09.002","article-title":"Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography","volume":"365","author":"Kand'ar","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0031","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41588-019-0504-x","article-title":"Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels","volume":"51","author":"Tin","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0032","doi-asserted-by":"crossref","first-page":"k3951","DOI":"10.1136\/bmj.k3951","article-title":"Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts","volume":"363","author":"Major","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0033","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000151292","article-title":"Low serum uric acid level is a risk factor for death in incident hemodialysis patients","volume":"29","author":"Lee","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0034","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/ki.1976.63","article-title":"Alterations of renal function during dietary-induced hyperuricemia in the rat","volume":"9","author":"Spencer","year":"1976","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00074.x","article-title":"Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats","volume":"67","author":"Sanchez-Lozada","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0036","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semnephrol.2004.09.004","article-title":"Hemodynamics of hyperuricemia","volume":"25","author":"Sanchez-Lozada","year":"2005","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0037","doi-asserted-by":"crossref","first-page":"F116","DOI":"10.1152\/ajprenal.00160.2006","article-title":"Effect of elevated serum uric acid on cisplatin-induced acute renal failure","volume":"292","author":"Roncal","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0038","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000238824","article-title":"Uric acid: a novel risk factor for acute kidney injury in high-risk cardiac surgery patients?","volume":"30","author":"Ejaz","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2011.06.021","article-title":"Elevated uric acid increases the risk for acute kidney injury","volume":"125","author":"Lapsia","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF00256698","article-title":"Hyperuricemia and hypoalbuminemia predispose to cisplatin-induced nephrotoxicity","volume":"17","author":"Nanji","year":"1986","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0041","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000448629","article-title":"Serum uric acid exhibits inverse relationship with estimated glomerular filtration rate","volume":"134","author":"Koratala","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119497","article-title":"Uric acid and the prediction models of tumor lysis syndrome in AML","volume":"10","author":"Ejaz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0043","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5414\/CN109815","article-title":"Effects of allopurinol pretreatment on the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials","volume":"93","author":"Xin","year":"2020","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0044","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0003319716644395","article-title":"Serum uric acid and risk for acute kidney injury following contrast","volume":"68","author":"Kanbay","year":"2017","journal-title":"Angiology"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0045","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.burns.2015.09.001","article-title":"Elevated serum uric acid after injury correlates with the early acute kidney in severe burns","volume":"41","author":"Liang","year":"2015","journal-title":"Burns"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0046","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2215\/CJN.05870614","article-title":"Plasma urate and risk of a hospital stay with AKI: the Atherosclerosis Risk in Communities Study","volume":"10","author":"Greenberg","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0047","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000443283","article-title":"Effects of serum uric acid on estimated GFR in cardiac surgery patients: a pilot study","volume":"42","author":"Ejaz","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0048","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11255-012-0192-2","article-title":"Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery","volume":"45","author":"Ejaz","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0049","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.12542","article-title":"Rasburicase in the prevention of laboratory\/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report","volume":"163","author":"Galardy","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0050","first-page":"HC03","article-title":"Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization","volume":"8","author":"Kumar","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0051","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000499939","article-title":"The role of uric acid in acute kidney injury","volume":"142","author":"Ejaz","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0052","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2369-15-122","article-title":"Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and meta-analysis based on observational cohort studies","volume":"15","author":"Li","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0053","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","article-title":"Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation","volume":"71","author":"Johnson","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0054","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0272-6386(04)00934-5","article-title":"Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort","volume":"44","author":"Iseki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","article-title":"Relationship of uric acid with progression of kidney disease","volume":"50","author":"Chonchol","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0056","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/HYPERTENSIONAHA.116.08998","article-title":"Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-year Japanese cohort study","volume":"69","author":"Kuwabara","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0057","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.ajkd.2008.12.021","article-title":"Uric acid and long-term outcomes in CKD","volume":"53","author":"Madero","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0058","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/EDE.0b013e3180646338","article-title":"Carbonated beverages and chronic kidney disease","volume":"18","author":"Saldana","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0059","doi-asserted-by":"crossref","first-page":"e3431","DOI":"10.1371\/journal.pone.0003431","article-title":"Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999-2004","volume":"3","author":"Shoham","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ki.2009.500","article-title":"Sugar-sweetened soda consumption, hyperuricemia, and kidney disease","volume":"77","author":"Bomback","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0061","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2215\/CJN.06380518","article-title":"Patterns of beverages consumed and risk of incident kidney disease","volume":"14","author":"Rebholz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0062","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2215\/CJN.03260410","article-title":"Associations of sugar and artificially sweetened soda with albuminuria and kidney function decline in women","volume":"6","author":"Lin","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0063","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3945\/ajcn.2009.28111","article-title":"Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"90","author":"Bomback","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0064","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2215\/CJN.03390316","article-title":"Diet soda consumption and risk of incident end stage renal disease","volume":"12","author":"Rebholz","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000066303","article-title":"Hyperuricemia causes glomerular hypertrophy in the rat","volume":"23","author":"Nakagawa","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0066","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0067","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","article-title":"Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism","volume":"282","author":"Mazzali","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0068","doi-asserted-by":"crossref","first-page":"F1134","DOI":"10.1152\/ajprenal.00104.2008","article-title":"Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia","volume":"295","author":"Sanchez-Lozada","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0069","doi-asserted-by":"crossref","first-page":"F1238","DOI":"10.1152\/ajprenal.00164.2006","article-title":"Effects of acute and chronic L-arginine treatment in experimental hyperuricemia","volume":"292","author":"Sanchez-Lozada","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0070","doi-asserted-by":"crossref","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","article-title":"Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease","volume":"304","author":"Ryu","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0071","doi-asserted-by":"crossref","first-page":"F373","DOI":"10.1152\/ajprenal.00104.2006","article-title":"Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB","volume":"292","author":"Han","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0072","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115210","article-title":"Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4","volume":"9","author":"Verzola","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0073","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3892\/ijmm.2015.2148","article-title":"Soluble uric acid increases NALP3 inflammasome and interleukin-1beta expression in human primary renal proximal tubule epithelial cells through the Toll-like receptor 4-mediated pathway","volume":"35","author":"Xiao","year":"2015","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0074","doi-asserted-by":"crossref","first-page":"e39738","DOI":"10.1371\/journal.pone.0039738","article-title":"Uric acid induces renal inflammation via activating tubular NF-kappaB signaling pathway","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/HYPERTENSIONAHA.116.08240","article-title":"Activation of renal (pro)renin receptor contributes to high fructose-induced salt sensitivity","volume":"69","author":"Xu","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0076","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/HJH.0b013e328337da1d","article-title":"Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction","volume":"28","author":"Yu","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0077","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1159\/000345509","article-title":"Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations","volume":"121","author":"Sanchez-Lozada","year":"2012","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0078","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ndt\/gfm783","article-title":"Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia","volume":"23","author":"Sanchez-Lozada","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0079","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202901","article-title":"Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage","volume":"13","author":"Garc\u00eda-Arroyo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002725","article-title":"No causal effects of serum urate levels on the risk of chronic kidney disease: a Mendelian randomization study","volume":"16","author":"Jordan","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0081","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","article-title":"Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors","volume":"3","author":"Yang","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0082","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000504267","article-title":"Genetically elevated serum uric acid and renal function in an apparently healthy population","volume":"104","author":"Ge","year":"2020","journal-title":"Urol Int."},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0083","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.jchromb.2009.05.037","article-title":"A sensitive and specific liquid chromatography-tandem mass spectrometry method for the determination of intracellular and extracellular uric acid","volume":"877","author":"Kim","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0084","doi-asserted-by":"crossref","first-page":"789","DOI":"10.4049\/jimmunol.2000319","article-title":"Soluble uric acid is an intrinsic negative regulator of monocyte activation in monosodium urate crystal-induced tissue inflammation","volume":"205","author":"Ma","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0085","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1038\/ncomms5642","article-title":"Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9","volume":"5","author":"DeBosch","year":"2014","journal-title":"Nat Commun."},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0086","doi-asserted-by":"crossref","first-page":"15501","DOI":"10.1073\/pnas.0904411106","article-title":"Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy","volume":"106","author":"Preitner","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0087","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2014.385","article-title":"No development of hypertension in the hyperuricemic liver-Glut9 knockout mouse","volume":"87","author":"Preitner","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0088","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187550","article-title":"Effects of uric acid-lowering therapy in patients with chronic kidney disease: a meta-analysis","volume":"12","author":"Su","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0089","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/0886022X.2018.1456463","article-title":"Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"40","author":"Liu","year":"2018","journal-title":"Ren Fail"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0090","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41581-019-0174-z","article-title":"The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD","volume":"15","author":"Sato","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0091","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","article-title":"Serum urate lowering with allopurinol and kidney function in type 1 diabetes","volume":"382","author":"Doria","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0092","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0093","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0094","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0020076","article-title":"Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis","volume":"2","author":"Wheeler","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0095","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1681\/ASN.2014070660","article-title":"Uric acid and cardiovascular events: a Mendelian randomization study","volume":"26","author":"Kleber","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0096","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijcard.2016.03.206","article-title":"A causal relationship between uric acid and diabetic macrovascular disease in Chinese type 2 diabetes patients: a Mendelian randomization analysis","volume":"214","author":"Yan","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0097","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4997\/jrcpe.2018.210","article-title":"Finding the truth: multivariable analysis and the assassination of Abraham Lincoln","volume":"48","author":"Johnson","year":"2018","journal-title":"J R Coll Physicians Edinb"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0098","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/euhj.2001.2970","article-title":"Urate predicts subsequent cardiac death in stroke survivors","volume":"23","author":"Wong","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0099","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/heartjnl-2014-305683","article-title":"Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial","volume":"100","author":"Higgins","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1755-5922.2008.00057.x","article-title":"Allopurinol treatment reduces arterial wave reflection in stroke survivors","volume":"26","author":"Khan","year":"2008","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0101","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1161\/STROKEAHA.108.519793","article-title":"Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial","volume":"39","author":"Muir","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0102","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-5223(19)36703-0","article-title":"A clinical trial of allopurinol (Zyloric) for myocardial protection","volume":"101","author":"Tabayashi","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0103","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-8703(91)90950-M","article-title":"A randomized controlled trial of allopurinol in coronary bypass surgery","volume":"121","author":"Johnson","year":"1991","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0104","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","article-title":"Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial","volume":"375","author":"Noman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/HYPERTENSIONAHA.115.06344","article-title":"Allopurinol and cardiovascular outcomes in adults with hypertension","volume":"67","author":"MacIsaac","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0106","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12883-016-0692-2","article-title":"Allopurinol and the risk of stroke in older adults receiving Medicare","volume":"16","author":"Singh","year":"2016","journal-title":"BMC Neurol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0107","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13075-016-1111-1","article-title":"Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims","volume":"18","author":"Singh","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0108","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12872-017-0513-6","article-title":"Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes","volume":"17","author":"Singh","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0109","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013774","article-title":"Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study","volume":"6","author":"Mackenzie","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0111","first-page":"S16","article-title":"Epidemiology of cardiovascular disease in chronic renal disease","volume":"9","author":"Foley","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0112","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1681\/ASN.2010111185","article-title":"Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease","volume":"22","author":"Kao","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0113","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/j.ajkd.2014.11.016","article-title":"Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial","volume":"65","author":"Goicoechea","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0114","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2015.05.017","article-title":"Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled trial","volume":"66","author":"Sircar","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0115","first-page":"iii118","article-title":"Allopurinol therapy for hyperuricemia reduces inflammation and progression of renal disease in moderate chronic kidney disease","volume":"29","author":"Tuta","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0116","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10157-012-0742-z","article-title":"Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study","volume":"17","author":"Terawaki","year":"2013","journal-title":"Clin Exp Nephrol."},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0117","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.ajkd.2006.08.019","article-title":"J-shaped mortality relationship for uric acid in CKD","volume":"48","author":"Suliman","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0118","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/ndt\/gfg563","article-title":"Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients","volume":"19","author":"Hsu","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0119","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2215\/CJN.00670111","article-title":"Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population","volume":"6","author":"Latif","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217859","article-title":"Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: a cohort study","volume":"14","author":"Sugano","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0121","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2215\/CJN.10400915","article-title":"Longitudinal study of serum uric acid, nutritional status, and mortality in maintenance hemodialysis patients","volume":"11","author":"Beberashvili","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0122","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s11255-019-02154-w","article-title":"Asymptomatic hyperuricemia and cardiovascular mortality in patients with chronic kidney disease who progress to hemodialysis","volume":"51","author":"Petreski","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0123","first-page":"1039","article-title":"The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia","volume":"17","author":"Jalalzadeh","year":"2012","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0124","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/hdi.12313","article-title":"Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: a randomized controlled study","volume":"19","author":"Tsuruta","year":"2015","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0125","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s11255-014-0731-0","article-title":"Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS","volume":"46","author":"Tsuruta","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0126","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jamacardio.2019.3201","article-title":"Dual-energy computed tomography detection of cardiovascular monosodium urate deposits in patients with gout","volume":"4","author":"Klauser","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0127","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1080\/15257770600890772","article-title":"Purine catabolism in advanced carotid artery plaque","volume":"25","author":"Felici","year":"2006","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0128","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/01.ATV.15.10.1616","article-title":"Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate","volume":"15","author":"Suarna","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0129","article-title":"Identification of uric acid and xanthine oxidase in atherosclerotic plaque","volume":"88","author":"Patetsios","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(73)90197-9","article-title":"Allopurinol treatment of uric-acid disorders in calcium-stone formers","volume":"1","author":"Coe","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0131","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2337\/dc10-1007","article-title":"Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease","volume":"33","author":"Rodrigues","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0132","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00592-014-0611-1","article-title":"Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study","volume":"51","author":"Bjornstad","year":"2014","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0133","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0134","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/art.41066","article-title":"Xanthine oxidase inhibitor withdrawal syndrome? Comment on the article by Choi et\u00a0al","volume":"71","author":"Johnson","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000105142","article-title":"The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease","volume":"27","author":"Talaat","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0136","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.118.033992","article-title":"Assessment of cardiovascular risk in older patients with gout initiating febuxostat versus allopurinol","volume":"138","author":"Zhang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0137","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/eurheartj\/ehz119","article-title":"Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy","volume":"40","author":"Kojima","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2020.12.004_bib0138","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ckj\/sfx036","article-title":"Lesinurad: what the nephrologist should know","volume":"10","author":"Sanchez-Nino","year":"2017","journal-title":"Clin Kidney J"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092952030139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092952030139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:37:23Z","timestamp":1759448243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027092952030139X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S027092952030139X"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2020.12.004","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2020.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}